At Sioux Falls Ford, we believe in the Value of Being Good Community Citizens. We give willingly to and are actively involved in the support of our communities, because they provide us our success.
We are proud to be the Local Presenting Sponsor of the Walk to End Alzheimer’s. Together, Sioux Falls Ford, and the Association will use our collective strengths to raise funds and awareness, enabling vital care and support services to be provided in the community while advancing critical research. Donation: $25,000.
MORE ABOUT WHAT THE WALK SUPPORTS
MORE ABOUT WHAT THE WALK SUPPORTS
- Fueling critical progress in dementia science — investing in over 1,000 active best-of-field research projects in 53 countries.
- We are in a new era of treatment, with FDA-approved drugs that can change disease progression in the early stages of Alzheimer’s disease.
- Partnering with clinicians to track outcomes of new treatments to improve the future of care.
- Current and future treatments will offer many facing Alzheimer’s more time with the people they love.
- Continuing to fight for a future where treatments are accessible for all people facing Alzheimer’s and all dementia — at every stage of the disease — in communities everywhere.
WHAT HAS CHANGED IN THE MEDICAL LANDSCAPE
With the U.S. Food and Drug Administration (FDA) approval of new drugs to treat Alzheimer’s disease and other promising interventions in the pipeline, the treatment landscape is changing rapidly. There’s no cure for Alzheimer’s, but there are treatments that may change disease progression, and drug and non-drug options that may help treat symptoms. Understanding available options can help individuals living with the disease and their caregivers to cope with symptoms and improve quality of life.
The FDA has approved medications for Alzheimer’s. These fall into two categories:
Drugs that temporarily ease some symptoms of Alzheimer’s disease.
While these medications do not stop the damage Alzheimer’s causes to brain cells, they may help lessen or stabilize symptoms for a limited time.
Drugs that change disease progression in people living with Alzheimer’s.
Drugs in this category slow disease progression. They slow the decline of memory and thinking, as well as function, in people living with Alzheimer’s disease.
LEARN THE FACTS
